A new blood test demonstrated higher sensitivity for detecting early-stage liver cancer compared to standard imaging in a large clinical trial. Helio Genomics announced the publication of a study in the Journal of Hepatology demonstrating that its HelioLiver blood test is more sensitive than ultrasound for the early detection of hepatocellular carcinoma (HCC). The results come from the CLiMB clinical trial, which evaluated the performance of the…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.